复发性阿弗他溃疡
- 网络recurrent aphthous ulcer;Rau;recurrent aphthous ulcer,RAU
-
目的:观察麻疹疫苗和复方丹参片联合用药治疗复发性阿弗他溃疡(RAU)的治疗效果。
Objective : To observe the curative effect of measles vaccine and compound danshen tablet on curing RAU .
-
康复新液联合西药治疗复发性阿弗他溃疡临床观察
Clinical Observation of Rehabilitation New Liquid Combined Western Medicine to Cure RAU
-
EGF及EGFR在口腔复发性阿弗他溃疡中的表达特征及意义
EGF and EGFR expression in recurrent aphthous ulcer and its significance
-
复发性阿弗他溃疡患者转录因子T-bet和GATA-3失衡表达的研究
Expression of T cell-specific transcription factors T-bet and GATA-3 in recurrent aphthous ulcerations
-
复发性阿弗他溃疡(recurrentaphthousulcer,RAU)是最常见的口腔粘膜疾病,患病率高达20%左右,居口腔粘膜病的首位。
Recurrent aphthous ulcer ( RAU ) is the most prevalent oral mucosal disease in humans , estimated to affect 20 % of the general population .
-
目的观察藿香正气散加减治疗复发性阿弗他溃疡(RAU)的疗效。
To evaluate the effects of Jiawei HuoXiang ZhengQi Powder on the treatment of recurrent aphthous ulcer ( RAU ) .
-
目的探讨复发性阿弗他溃疡(RAU)与人巨细胞病毒(HCMV)和单纯疱疹病毒(HSV)感染的相关性。
Objective To explore the correlation between recurrent aphthous ulcer ( RAU ) and infection of human cytomegalovirus ( HCMV ), herpes simplex virus ( HSV ) .
-
目的探讨转录因子T-bet和GATA-3在复发性阿弗他溃疡(RAU)免疫失衡中的意义。
Objective To investigate the expression of the T cell-specific transcription factors T-bet / GATA-3 in recurrent aphthous ulcerations ( RAU ) .
-
皮下注射转移因子治疗复发性阿弗他溃疡远期疗效的成本效果分析
Cost-effectiveness analysis of transfer factor subcutaneous injection for recurrent aphthous ulcer
-
丁卡因治疗复发性阿弗他溃疡的疗效观察
Study of the effect of recurrent aphthous ulcer treated with dicaine
-
表皮生长因子受体蛋白和基因在口腔复发性阿弗他溃疡中表达的变化及意义
EGFR Protein and Gene Expression in Recurrent Aphthous Ulcer and Their Significance
-
复发性阿弗他溃疡与病毒感染的相关性研究
Study on correlation between recurrent aphthous ulcer and virus infection
-
增殖细胞核抗原在口腔复发性阿弗他溃疡的表达及意义
Proliferating cell nuclear antigen expression in recurrent aphthous ulcer and its significance
-
氨来呫诺糊剂治疗复发性阿弗他溃疡临床疗效试验研究
A clinical study on the treatment of recurrent aphthous ulcer with amlexanox paste
-
幽门螺旋杆菌在复发性阿弗他溃疡中的意义
The effect of helicobacter pylori in the pathogenic process of recurrent aphthous ulcer
-
幽门螺杆菌与复发性阿弗他溃疡
Recurrent Aphthous Ulcer and Helicobacter Pylori
-
复发性阿弗他溃疡患者的大颗粒淋巴细胞检测分析
Q & a on sex an analysis about the numbers of LGL in patients with RAU
-
复发性阿弗他溃疡与菌斑指数的关系
Plaque index in recurrent aphthous ulcerations
-
结论甲磺酸左氧氟沙星可有效治疗耐青霉素肺炎链球菌性肺炎。肺炎链球菌在复发性阿弗他溃疡中的致病作用
Conclusion Levofloxacin could treat the PRSP infection effectively . Pathogenesis of Pneumococci in Recurrent Aphthous Ulcers
-
丹参复方双链酶药膜治疗复发性阿弗他溃疡的临床初步研究
A clinical preliminary study on the effects of Danshen root / SK-SD sensitive layer to RAU
-
结论雷公藤多苷可明显促进顽固复发性阿弗他溃疡愈合,延长复发间隔期,减少复发次数。
Conclusion TG could promote healing of stubborn RAU , extend the recurrence interval and reduce relapses .
-
转移因子联合半导体激光治疗复发性阿弗他溃疡的短期疗效观察
Short-term evaluation of the clinical efficacy of transfer factor in combination with semiconductor laser on recurrent aphthous ulcer
-
卡介菌多糖核酸治疗疱疹样复发性阿弗他溃疡疗效及T细胞亚群变化分析
Outcomes of treating herpetiform ulcer with polysaccharide nucleic acid of bacillus calmette-guerin and changs of T lymphocyte subsets
-
目的:评价黄芪颗粒治疗复发性阿弗他溃疡的远期疗效和安全性。
Objective : To assess the long-term efficacy and safety of Astragalus granule in treatment of recurrent aphthous ulcer .
-
复发性阿弗他溃疡患者间歇期和溃疡期辅助性T细胞细胞因子的变化
The Changes of T Helper Cell Secreting Cytokines in Patients with Recurrent Aphthous Ulcer at Ulcer and Intermission Stages
-
目的观察雷公藤多苷治疗顽固复发性阿弗他溃疡的临床效果。
Objective To investigate the clinical effect of tripterygium glycosides ( TG ) on stubborn recurrent aphthous ulcer ( RAU ) .
-
结论:口安饮可用于治疗复发性阿弗他溃疡,减少复发溃疡数,延长复发间歇时间。
CONCLUSION : Kouanyin can be applied to treatment of recurrent aphthous ulcer by reducing the numbers of ulcer and prolonging the recurrence in ˉ terval .
-
结果处方诊断所涉及的病种共计30多种,处方数量排名前3位的口腔粘膜病依次是口腔扁平苔藓、复发性阿弗他溃疡和口腔念珠菌病;
RESULTS : The entities involved in the prescriptions totaled more than 30.Dominated the first 3 places in the list of prescription number of oral mucosal diseases were oral lichen planus , recurrent aphthous ulcer and oral candidiasis , respectively .